Navigation Links
Identification of new genes shows a complex path to cell death
Date:12/14/2007

WORCESTER, Mass. Can a tiny winged insects salivary glands really tell us about processes relevant to human disease" Yes, according to a new study by researchers at the University of Massachusetts Medical School (UMMS), who gained new insights into autophagya cellular degradation process associated with a form of programmed cell deathby studying the salivary gland cells of the fruit fly.

Since its initial discovery in the 1960s, programmed cell death has been a primary focus of studies for investigators across a wide array of scientific disciplines. An essential mechanism in development and homeostasis, programmed cell death allows for the clean intracellular destruction of unnecessary or damaged cells. While apoptosis is the most understood type of programmed cell death, recently scientists have begun to take a closer look at autophagy a highly regulated, catabolic process that essentially allows a cell to eat itself. Paradoxically, autophagy is not only a major mechanism by which a starving cell reallocates nutrients to ensure survival, scientists are now demonstrating that autophagy also provides cells that cannot undergo apoptosis with an alternate form of self-destruction.

In Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila, published in the December 14 issue of Cell, Eric Baehrecke, PhD, UMMS Associate Professor of Cancer Biology, and colleagues examined fly salivary glands, which contain all of the machinery required to dismantle and recycle their own cellular components and thus provide a genetic model system for elucidating the complex functions of autophagy. The paper describes the cellular components required for autophagic cell death and defines multiple pathways that cooperate in the clearance of cells during fly development. Further, their findings demonstrate a critical relationship between growth and this form of cell death.

When cells keep growing, they dont die well, Dr. Baehrecke explained. We show that an arrest of growth preceded the death of these cells. If we maintain growth by turning on certain genes, we can block the death of these cells, and this has potential clinical implications. Therapies directed at apoptotic mechanisms have resulted in limited success; we hope that further studies of autophagy could lead to new approaches to the treatment of human disease.

Its becoming increasingly important to understand how the various cell death pathways connect and how they affect development, the stress response, and disease, said Marion Zatz, PhD, who oversees cell death grants at the National Institute of General Medical Sciences, which funded the work. While this research was done in fruit flies, findings made in model organisms are often the first step in understanding what goes on in humans. By shedding light on autophagic cell death, this work may help explain the pathways role in human diseases such as cancer, Alzheimers and Parkinsons.

The role of autophagy during cell death remains controversial but is important to our understanding and treatment of many human disorders including cancer and neurodegeneration, Baehrecke said. It is important to understand the relationship between autophagy and cell death, as the association of autophagy with cell growth, nutrient utilization, survival and death indicates that this catabolic process is relevant to the treatment of many human disorders including cancer.


'/>"/>

Contact: Kelly Bishop
kelly.bishop@umassmed.edu
University of Massachusetts Medical School
Source:Eurekalert

Related medicine news :

1. Community Health Centers Reveal Specific Ramifications of The Medicaid Citizenship and Identification Documentation Requirements
2. Pathway links inflammation, angiogenesis and breast cancer
3. Traffic Fumes Plus Genes Boosts Kids Asthma Risk
4. New Database to Help Speed Search for Bipolar Disorder Genes
5. Is Perfect Pitch All in the Genes?
6. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
7. Genes Boost Risk for Rheumatoid Arthritis, Lupus
8. The genes involved in rheumatoid arthritis identified
9. If you think cancer genes are simple, you dont know JAK
10. Test for lung cancer looks for discomforting quiet among protective genes
11. Hushed Genes Might Mean Higher Lung Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... As part of its ongoing series of ... Each webinar features a dynamic expert and thoughtful presentation to give attendees a ... facilities. Both events are free to attend, but registration is required. ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to stabilize ... can leave patients with dental emergencies at risk of losing a tooth or their ... care. , Common dental emergencies include:, , Avulsed or ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 Executive ... than 200 of the country’s top healthcare executives to share insights on transformational ... of the Forum is the provider-centric perspective, experience, expertise and strategy shared by ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... award winner and inspirational speaker Jan Fox will serve as keynote speaker at ... will provide participants with tools to more effectively communicate with their own organizational ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined ... readily available to physicians. The integration will enable Allscripts users to post open ... Everseat’s free mobile app. , The partnership gives Everseat substantial added power to ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- CSI Specialty Group (CSI) expanded its specialty pharmacy ... Pharmacy Podcast. A free, weekly show, the Specialty Pharmacy ... discussion and context amongst specialty pharmacy peers and professionals. ... The Specialty Pharmacy Podcast, hosted by industry leader ... DiMascio, CHE, CMCE, CPC, is available for streaming and/or ...
(Date:2/10/2016)... and SAN DIEGO , Feb. 10, ... global leader in viral gene therapy manufacturing, and Renova™ ... congestive heart failure and other chronic diseases, have entered ... manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product ... --> --> This relationship ...
(Date:2/10/2016)... -- Urologix, the market leader for in-office minimally invasive ... (BPH), announces new private ownership and is operating as ... industry veteran of more than 20 years, has been ... Plymouth, Minn. The company,s two ... RF Therapy, will continue to be broadly available and ...
Breaking Medicine Technology: